Skip to main content

Allergen Immunotherapy

Section edited by Gianenrico Senna 

  1. The concept of personalized medicine as a diagnostic and therapeutic approach tailored to the medical needs of each patient is currently revolutionizing all fields of medicine and in particular allergology. Al...

    Authors: Cristoforo Incorvaia, Erminia Ridolo, Diego Bagnasco, Silvia Scurati and Giorgio Walter Canonica
    Citation: Clinical and Molecular Allergy 2021 19:10
    Content type: Commentary Published on:

  2. House-dust mites (HDM) allergy is the prevailing condition in subjects allergic to inhalants. Clinical studies with HDM extracts—either subcutaneous (SCIT) or sublingual (SLIT) have long been characterized by ...

    Authors: Gianfranco Vitiello, Lucia Maltagliati and Oliviero Rossi
    Citation: Clinical and Molecular Allergy 2020 18:10
    Content type: Review Published on:

  3. Sublingual immunotherapy (SLIT) is effective, tolerable, and convenient for many allergic patients. Still, real-world evidence is scarce and the aim of this study is to assess the patient reported outcome of t...

    Authors: Christer Janson, Fredrik Sundbom, Peter Arvidsson and Mary Kämpe
    Citation: Clinical and Molecular Allergy 2018 16:14
    Content type: Research Published on:

  4. Allergen immunotherapy (AIT) is the only disease-modifying treatment approved for allergic rhinitis and allergic asthma and represents a suitable therapeutic option, especially in childhood, to modify the prog...

    Authors: Matteo Ferrando, Francesca Racca, Lorena Nascimento Girardi Madeira, Enrico Heffler, Giovanni Passalacqua, Francesca Puggioni, Niccolò Stomeo and Giorgio Walter Canonica
    Citation: Clinical and Molecular Allergy 2018 16:6
    Content type: Review Published on:

  5. Asthma, allergic rhinitis (AR) and atopic dermatitis are very common in young people, but in the latest decades it was increasingly recognized that also individuals of higher ages, including the population ove...

    Authors: Erminia Ridolo, Anti Rogkakou, Maria Teresa Ventura, Irene Martignago, Cristoforo Incorvaia, Gabriele Di Lorenzo and Giovanni Passalacqua
    Citation: Clinical and Molecular Allergy 2017 15:17
    Content type: Review Published on:

  6. Sublingual immunotherapy (SLIT) is a feasible option to classical subcutaneous immunotherapy to treat respiratory allergy and is increasingly prescribed in Europe. However, the lack of reimbursement may limit ...

    Authors: Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia and Carlo Lombardi
    Citation: Clinical and Molecular Allergy 2017 15:15
    Content type: Research Published on:

  7. Allergen-specific immunotherapy (AIT) is the only treatment able to change the natural course of allergic diseases. We aimed at investigating the clinical efficacy of SLITOR (Serbian registered vaccine for sub...

    Authors: I. Djuric-Filipovic, Marco Caminati, D. Filipovic, C. Salvottini and Z. Zivkovic
    Citation: Clinical and Molecular Allergy 2017 15:7
    Content type: Research Published on:

  8. Allergic rhinitis has a very high burden regarding both direct and indirect costs. This makes essential in the management of AR to reduce the clinical severity of the disease and thus to lessen its costs. This...

    Authors: Carlo Lombardi, Valerie Melli, Cristoforo Incorvaia and Erminia Ridolo
    Citation: Clinical and Molecular Allergy 2017 15:5
    Content type: Review Published on:

  9. Airborne allergens can induce an immunological chronic disease characterized by airway hyper responsiveness and inflammation, mediated by exaggerated Th2 immune response. Allergen-specific immunotherapy (AIT) ...

    Authors: Claudia Petrarca, Emanuela Clemente, Valentina Amato, Alessia Gatta, Sara Cortese, Alessia Lamolinara, Cosmo Rossi, Stefania Zanotta, Gianni Mistrello, Roberto Paganelli and Mario Di Gioacchino
    Citation: Clinical and Molecular Allergy 2016 14:7
    Content type: Research Published on:

  11. Allergic respiratory diseases are constantly increasing in prevalence. Allergen Immunotherapy (AIT) represent a valuable therapeutic tool as symptomatic and preventative approach, expecially in children. In It...

    Authors: Massimo Landi, Paolo Meglio, Ermanno Praitano, Carlo Lombardi, Giovanni Passalacqua and Giorgio Walter Canonica
    Citation: Clinical and Molecular Allergy 2015 13:15
    Content type: Research Published on:


The official journal of the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC)

Submit manuscript

Annual Journal Metrics

Clinical and Molecular Allergy

ISSN: 1476-7961

Contact us